These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


421 related items for PubMed ID: 20942667

  • 1. Antiretroviral treatment for children with peripartum nevirapine exposure.
    Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Schimana W, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Violari A.
    N Engl J Med; 2010 Oct 14; 363(16):1510-20. PubMed ID: 20942667
    [Abstract] [Full Text] [Related]

  • 2. Antiretroviral therapies in women after single-dose nevirapine exposure.
    Lockman S, Hughes MD, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata RA, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors JW, Schooley RT, Currier JS, OCTANE A5208 Study Team.
    N Engl J Med; 2010 Oct 14; 363(16):1499-509. PubMed ID: 20942666
    [Abstract] [Full Text] [Related]

  • 3. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.
    Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Palumbo P.
    N Engl J Med; 2012 Jun 21; 366(25):2380-9. PubMed ID: 22716976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial.
    Coovadia A, Abrams EJ, Strehlau R, Shiau S, Pinillos F, Martens L, Patel F, Hunt G, Tsai WY, Kuhn L.
    JAMA; 2015 Nov 03; 314(17):1808-17. PubMed ID: 26529159
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
    Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V, Perinatal HIV Prevention Trial (Thailand) Investigators.
    N Engl J Med; 2004 Jul 15; 351(3):217-28. PubMed ID: 15247338
    [Abstract] [Full Text] [Related]

  • 8. Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.
    Coovadia A, Abrams EJ, Stehlau R, Meyers T, Martens L, Sherman G, Hunt G, Hu CC, Tsai WY, Morris L, Kuhn L.
    JAMA; 2010 Sep 08; 304(10):1082-90. PubMed ID: 20823434
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir.
    Dlamini JN, Hu Z, Somaroo H, Highbarger HC, Follmann DA, Dewar RL, Pau AK.
    Pharmacotherapy; 2011 Feb 08; 31(2):158-63. PubMed ID: 21275494
    [Abstract] [Full Text] [Related]

  • 10. Antiretroviral interventions for preventing breast milk transmission of HIV.
    White AB, Mirjahangir JF, Horvath H, Anglemyer A, Read JS.
    Cochrane Database Syst Rev; 2014 Oct 04; 2014(10):CD011323. PubMed ID: 25280769
    [Abstract] [Full Text] [Related]

  • 11. Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission.
    Lindsey JC, Hughes MD, Violari A, Eshleman SH, Abrams EJ, Bwakura-Dangarembizi M, Barlow-Mosha L, Kamthunzi P, Sambo PM, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Zimmer B, Petzold E, Mofenson LM, Jean-Philippe P, Palumbo P, P1060 Study Team.
    Pediatr Infect Dis J; 2014 Aug 04; 33(8):846-54. PubMed ID: 25222305
    [Abstract] [Full Text] [Related]

  • 12. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
    Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM, IMPAACT 1077BF/1077FF PROMISE Study Team.
    N Engl J Med; 2016 Nov 03; 375(18):1726-1737. PubMed ID: 27806243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE.
    N Engl J Med; 2008 Jul 10; 359(2):119-29. PubMed ID: 18525035
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
    Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP, CEPAC-International and OCTANE Investigators.
    AIDS; 2011 Feb 20; 25(4):479-92. PubMed ID: 21293199
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.